Sofinnova Ventures »

Rayzebio shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Rayzebio shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Rayzebio

Tip: Access up to 7 years of quarterly data

All positions including Rayzebio held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rayzebio by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $54M 2.4M 22.20

More positions owned by Sofinnova Ventures

Karuna Therapeutics Ord
Natera (NTRA)
AstraZeneca Sponsored Adr (AZN)
Merck & Co (MRK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Rayzebio
Dex (DXCM)
Aerovate Therapeutics (AVTE)
Intuitive Surgical (ISRG)
Vera Therapeutics Cl A (VERA)
Cytokinetics (CYTK)
Elanco Animal Health (ELAN)
IShares TR Russell 2000 Etf Put Option (IWM)
argenx SE Sponsored Adr (ARGX)
Exelixis Put Option (EXEL)

View all positions for Sofinnova Ventures

Top funds holding Rayzebio

Viking Global Investors
venBio Partners
Versant Venture Management
VR Adviser
Wellington Management Company
OrbiMed Advisors
Redmile Group
Samsara BioCapital
Fairmount Funds Management
Cormorant Asset Management
Vanguard Group
Hillhouse Capital Advisors
Deerfield Management Company
Alliancebernstein
Laurion Capital Management

View all funds holding Rayzebio